Mark J. Holterman: Contributions to Medical Research

Dr. Mark J. Holterman is a pediatric surgeon working at the Children’s Hospital of Illinois, St. Francis Medical Center and the Advocate Christ Children’s Hospital. He is also a full-time professor instructing at the University of Illinois College of Medicine. He is an active member of the American College of Surgeons, as well as the American Academy of Pediatrics. Dr. Mark J. Holterman also does a lot of research, focusing mainly on stem cell treatment and regenerative medicine. He is also known for treating cancer and obesity, especially among the children. Dr. Mark J. Holterman attended Yale University when he was in college. He graduated cum laude and received his degree in Biology. He decided to take up his master’s and doctor’s degree at the University of Virginia, and he completed his residency and fellowship at the University of Virginia Health Sciences and the University of Washington Children’s Hospital and Medical Center, respectively (https://doctor.webmd.com/doctor/mark-holterman-md-a978422c-387f-40a8-b4b3-b5894444d1af-overview).

 

Dr. Mark J. Holterman is known for contributing a lot to the innovation and development of medical science. He co-founded the Alliance for the Advancement of Cellular Therapies, a group whose primary objective is to develop treatments such as stem cell therapy (MarkHolterman.WordPress). He is also serving as the group’s executive board, and he is responsible for the collaboration between the Alliance for the Advancement of Cellular Therapies and CellR4, a journal which publishes information taken from the conference hosted by the organization of Dr. Mark J. Holterman.

 

CellR4 is focusing on the researchers and studies about the idea of repairing the cells, regeneration of the cells, reprogramming of the cells, and the differentiation of the cells. The publication is stating facts on why therapies which alter the cells are beneficial and can also be dangerous to mankind. It is also presenting the challenges and opportunities that the scientists are facing when thinking about the development of new treatments. The decision of Dr. Mark J. Holterman to collaborate with CellR4 is lauded by his colleagues, stating that it is advantageous for the Alliance for the Advancement of Cellular Therapies. Aside from researching about cellular alteration therapies, Dr. Mark J. Holterman is also researching about diabetes and has been awarded for his cause.